FDA approval makes Xolair the first available biologic for children ages 6 and up with uncontrolled allergic asthma.
The outlook remains bright due to a favorable regulatory arena, support for biopharma-friendly legislation and development incentives, expanding scientific opportunities in key therapeutic areas such as immuno-oncology, and big pharma’s continued push to obtain innovation.
Vifor Fresenius Medical Care Renal Pharma obtains rights to commercialize RAYALDEE in Europe, Canada and certain other international markets; OPKO Health to receive up to $282 million in upfront and milestone payments, plus tiered double-digit royalties.
– Odefsey is the Smallest Single Tablet HIV Regimen – FOSTER CITY, Calif.–(BUSINESS WIRE)– Gilead Sciences, Inc. (GILD) today announced that the U.S. Food and Drug Administration (FDA) has […]
The pharma industry’s R&D concentration has been shifting towards specialty therapy areas as research and development returns decline for some leaders.
January 29, 2016 Dayton, N.J. – Aurobindo Pharma Limited has received final approval from the U.S. Food and Drug Administration for Voriconazole Tablets, 50 mg and 200 mg. The […]
HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy’s Laboratories (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that the U.S. Food and Drug Administration (FDA) has approved ZEMBRACE™SymTouch™ (sumatriptan succinate) injection, […]
Executives from the 2015 and 2014 Manny Award winners and finalists share their views on a variety of industry-related topics.
For the eighth year, Med Ad News has chosen three Pharmaceutical Marketing Ventures to Watch that could change the way pharmaceutical products are marketed and sold.
First Digestive Enzyme Cartridge Designed for Patients on Enteral Feeding December 02, 2015 07:00 AM Eastern Standard Time NEWTON, Mass.–(BUSINESS WIRE)–Alcresta Pharmaceuticals, a specialty pharmaceutical company focused […]
